Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (26) Bladder Cancer
...X]   Switzerland • [X]   Thailand California Berkley : Alta Bates Summit Comprehensive Cancer Center Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer (CILAB ...
...BEVERLY HILLS : FOUNDATION/ TOWER HEMATOLOGY ONCOLOGY First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplastin-Based Therapy Beverly Hills : Foundation/ Tower Hematology Oncology ...
View Page

2.  CenterWatch: Clinical Trials in Category (35) Pancreatic Cancer
...First-line Treatment of Unresectable Locally Advanced Pancreatic Cancer Savannah : Memorial Health University Medical Center Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be ...
...Pancreatic Cancer Rosario : Research Site: A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Santa Fe : Research Site: A Biomarker Identification Trial of ...
View Page

3. Clinical Trial Results by Drug Names
...A randomized double-blind multicenter phase III study of bevacizumab in combination with cisplatin and gemcitabine versus placebo, cisplatin and gemcitabine in patients with advanced or recurrent non-squamous non-small cell lung cancer, who have ...
View Page

4.  Study Posting (4519) Trial #117373, Non-Small Cell Lung Cancer, Wollongong, Australia
...Non-Small Cell Lung Cancer, Wollongong, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

5.  Study Posting (4519) Trial #118331, Non-Small Cell Lung Cancer, Wodonga, Australia
...Non-Small Cell Lung Cancer, Wodonga, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

6.  Study Posting (4519) Trial #117435, Non-Small Cell Lung Cancer, Richmond, Australia
...Non-Small Cell Lung Cancer, Richmond, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

7.  Study Posting (4519) Trial #117351, Non-Small Cell Lung Cancer, Parkville, Australia
...Non-Small Cell Lung Cancer, Parkville, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

8.  Study Posting (4519) Trial #117361, Non-Small Cell Lung Cancer, Melbourne, Australia
...Non-Small Cell Lung Cancer, Melbourne, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

9.  Study Posting (4519) Trial #117434, Non-Small Cell Lung Cancer, Lismore, Australia
...Non-Small Cell Lung Cancer, Lismore, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

10.  Study Posting (4519) Trial #117446, Non-Small Cell Lung Cancer, Greenslopes, Australia
...Non-Small Cell Lung Cancer, Greenslopes, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

11.  Study Posting (4519) Trial #160277, Non-Small Cell Lung Cancer, Footscray, Australia
...Non-Small Cell Lung Cancer, Footscray, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

12.  Study Posting (4519) Trial #147374, Non-Small Cell Lung Cancer, Brisbane, Australia
...Non-Small Cell Lung Cancer, Brisbane, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

13.  Study Posting (4519) Trial #117436, Non-Small Cell Lung Cancer, St. Leonards, Australia
...Small Cell Lung Cancer, St. Leonards, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: Completed Protocol Number ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

14.  Study Posting (4519) Trial #135098, Non-Small Cell Lung Cancer, Perth, Australia
...Non-Small Cell Lung Cancer, Perth, Australia Trial Information A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer. Status: No longer recruiting ...
...Title: A randomized, open label study comparing the effect of first-line therapy with Tarceva + gemcitabine versus gemcitabine monotherapy on treatment response in treatment-naïve patients with advanced non-small cell ...
View Page

15.  Study Posting (4445) Trial #118505, Non-Small Cell Lung Cancer, Raleigh, NC
...Lung Cancer, Raleigh, NC Trial Information Randomized Phase II Study of First-Line Treatment with Gemcitabine vs. Erlotinib vs. Gemcitabine and Erlotinib in Elderly Patients with Stage (IIIB/IV) Non-Small Cell Lung Cancer This ...
View Page

16.  Study Posting (4962) Trial #144292, Solid Tumors, Santa Monica, CA
...Information A Phase I Dose-Escalation Study of SCH900776 as Monotherapy and in Combination with Gemcitabine in Subjects with Advanced Solid Tumors or Lymphoma This study is designed to test the ...
...given first as a single agent (monotherapy) for one cycle and then in combination with Gemcitabine. Gemcitabine is an FDA approved drug that works by damaging the DNA of cancer cells ...
View Page

17.  Study Posting (4519) Trial #160627, Non-Small Cell Lung Cancer, Woolloongabba, Australia
...Lung Cancer, Woolloongabba, Australia Trial Information A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer Status: Recruiting ...
...label study of the effect of first line treatment with Tarceva in sequential combination with gemcitabine, compared to gemcitabine monotherapy, on progression-free survival in elderly or ECOG PS of 2 ...
View Page

18.  Study Posting (4519) Trial #157167, Non-Small Cell Lung Cancer, Wollongong, Australia
...Lung Cancer, Wollongong, Australia Trial Information A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer Status: Recruiting ...
...label study of the effect of first line treatment with Tarceva in sequential combination with gemcitabine, compared to gemcitabine monotherapy, on progression-free survival in elderly or ECOG PS of 2 ...
View Page

19.  Study Posting (4519) Trial #157259, Non-Small Cell Lung Cancer, Wodonga, Australia
...Lung Cancer, Wodonga, Australia Trial Information A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer Status: Recruiting ...
...label study of the effect of first line treatment with Tarceva in sequential combination with gemcitabine, compared to gemcitabine monotherapy, on progression-free survival in elderly or ECOG PS of 2 ...
View Page

20.  Study Posting (4519) Trial #157103, Non-Small Cell Lung Cancer, Sydney, Australia
...Lung Cancer, Sydney, Australia Trial Information A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer Status: Recruiting ...
...label study of the effect of first line treatment with Tarceva in sequential combination with gemcitabine, compared to gemcitabine monotherapy, on progression-free survival in elderly or ECOG PS of 2 ...
View Page